Conference Coverage
Conference Coverage
Two multitarget stool tests show promise for CRC screening: Studies
"This is the first large study to include the 45- to 49-year-old population, for whom screening is now recommended."
Conference Coverage
RSV more common in IBD
Study details higher rates of RSV in patients with IBD, plus cases are more serious.
Conference Coverage
New study ties ultra-processed foods to IBD
Adults who consumed diets rich in ultra-processed foods were shown to have an elevated relative risk for IBD, Crohn’s disease, and ulcerative...
Conference Coverage
Subcutaneous ocrelizumab, ofatumumab ‘reassuring’ in MS
The study “makes me feel pretty comfortable that regardless of where you’re delivering the therapy, IV or subcutaneously, it’s getting in there...
Conference Coverage
Promising topline phase 2 results for novel oral Alzheimer’s drug
The data suggest that a “high plasma pTau-217/non–pTau-217 ratio, a marker of AD pathology, likely defines an AD population responsive to T3D-959...
Conference Coverage
Lag in antidepressant treatment response explained?
Compared with the placebo group, participants taking escitalopram had a marked increase in synaptic density.
Conference Coverage
How clinicians can prepare for and defend against social media attacks
Conference Coverage
Postmenopausal stress linked to mood, cognitive symptoms
Hair cortisol offers a novel way to collect data on chronic stress in postmenopausal women, the lead researcher suggested.
Conference Coverage
Bariatric surgery, including sleeve gastrectomy, linked to fracture risk
A study of a largely male veteran population reinforces observations in younger women and underscores concerns about osteoporosis in men.
Conference Coverage
Tricyclics may raise fracture risk in type 2 diabetes
Although the findings are suggestive, they don’t definitively pin blame on tricyclic antidepressants alone in directly leading to fractures.
Latest News
Recombinant IL-2 shows potential in atopic dermatitis
Rezpegaldesleukin is now being evaluated in a phase 2b study for moderate to severe atopic dermatitis, and a phase 2b trial for alopecia areata is...